Sensus Healthcare PE Ratio 2014-2025 | SRTS
Current and historical p/e ratio for Sensus Healthcare (SRTS) from 2014 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Sensus Healthcare PE ratio as of June 04, 2025 is 48.30.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Sensus Healthcare PE Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | TTM Net EPS | PE Ratio |
2025-06-04 | 4.89 | 48.90 | |
2025-03-31 | 4.73 | $0.10 | 47.30 |
2024-12-31 | 6.92 | $0.40 | 17.30 |
2024-09-30 | 5.80 | $0.57 | 10.18 |
2024-06-30 | 5.33 | $0.41 | 13.00 |
2024-03-31 | 3.80 | $0.29 | 13.10 |
2023-12-31 | 2.36 | $0.03 | 78.67 |
2023-09-30 | 2.77 | $-0.06 | 0.00 |
2023-06-30 | 3.15 | $0.14 | 22.50 |
2023-03-31 | 5.21 | $0.37 | 14.08 |
2022-12-31 | 7.42 | $1.46 | 5.08 |
2022-09-30 | 12.53 | $1.61 | 7.78 |
2022-06-30 | 7.68 | $1.51 | 5.09 |
2022-03-31 | 10.12 | $1.28 | 7.91 |
2021-12-31 | 7.22 | $0.24 | 30.08 |
2021-09-30 | 3.60 | $-0.02 | 0.00 |
2021-06-30 | 3.85 | $-0.13 | 0.00 |
2021-03-31 | 3.83 | $-0.27 | 0.00 |
2020-12-31 | 3.86 | $-0.42 | 0.00 |
2020-09-30 | 2.52 | $-0.42 | 0.00 |
2020-06-30 | 3.06 | $-0.36 | 0.00 |
2020-03-31 | 2.50 | $-0.19 | 0.00 |
2019-12-31 | 3.54 | $-0.10 | 0.00 |
2019-09-30 | 6.00 | $-0.15 | 0.00 |
2019-06-30 | 5.54 | $-0.14 | 0.00 |
2019-03-31 | 7.02 | $-0.19 | 0.00 |
2018-12-31 | 7.41 | $-0.14 | 0.00 |
2018-09-30 | 8.38 | $-0.18 | 0.00 |
2018-06-30 | 7.26 | $-0.22 | 0.00 |
2018-03-31 | 5.84 | $-0.24 | 0.00 |
2017-12-31 | 5.16 | $-0.28 | 0.00 |
2017-09-30 | 4.98 | $-0.25 | 0.00 |
2017-06-30 | 4.02 | $-0.18 | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $0.079B | $0.042B |
Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Intuitive Surgical (ISRG) | United States | $197.793B | 86.63 |
Thermo Fisher Scientific (TMO) | United States | $150.971B | 18.26 |
Edwards Lifesciences (EW) | United States | $45.591B | 29.89 |
IDEXX Laboratories (IDXX) | United States | $42.288B | 48.60 |
Alcon (ALC) | Switzerland | $42.138B | 28.48 |
DexCom (DXCM) | United States | $34.031B | 52.60 |
IQVIA Holdings (IQV) | United States | $24.701B | 13.84 |
Mettler-Toledo (MTD) | United States | $24.242B | 28.83 |
STERIS (STE) | Ireland | $23.937B | 26.36 |
Waters (WAT) | United States | $20.792B | 29.34 |
SONOVA HOLDING (SONVY) | Switzerland | $18.231B | 0.00 |
Hologic (HOLX) | United States | $14.048B | 15.26 |
Sysmex ADR (SSMXY) | Japan | $10.336B | 29.32 |
Penumbra (PEN) | United States | $9.967B | 78.22 |
Masimo (MASI) | United States | $8.883B | 32.77 |
Globus Medical (GMED) | United States | $8.082B | 19.26 |
Glaukos (GKOS) | United States | $5.399B | 0.00 |
Teleflex (TFX) | United States | $5.366B | 8.86 |
TransMedics (TMDX) | United States | $4.355B | 94.66 |
Integer Holdings (ITGR) | United States | $4.182B | 21.91 |
PROCEPT BioRobotics (PRCT) | United States | $3.319B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.405B | 14.32 |
Veracyte (VCYT) | United States | $2.075B | 29.12 |
Nihon Kohden (NHNKY) | Japan | $2.022B | 23.20 |
Elekta AB (EKTAY) | Sweden | $1.956B | 17.59 |
Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
Tandem Diabetes Care (TNDM) | United States | $1.374B | 0.00 |
Artivion (AORT) | United States | $1.215B | 113.80 |
Pulse Biosciences (PLSE) | United States | $1.186B | 0.00 |
OPKO Health (OPK) | United States | $1.094B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.013B | 5.39 |
SiBone (SIBN) | United States | $0.805B | 0.00 |
Beta Bionics (BBNX) | United States | $0.779B | 0.00 |
IRadimed (IRMD) | United States | $0.760B | 38.57 |
RxSight (RXST) | United States | $0.642B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.576B | 8.96 |
Delcath Systems (DCTH) | United States | $0.560B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.546B | 12.80 |
AxoGen (AXGN) | United States | $0.517B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.496B | 0.00 |
AngioDynamics (ANGO) | United States | $0.445B | 0.00 |
NeuroPace (NPCE) | United States | $0.444B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.432B | 0.00 |
Semler Scientific (SMLR) | United States | $0.397B | 10.56 |
Treace Medical Concepts (TMCI) | United States | $0.365B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.354B | 0.00 |
Pacific Biosciences Of California (PACB) | United States | $0.315B | 0.00 |
Neuronetics (STIM) | United States | $0.254B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.239B | 14.48 |
908 Devices (MASS) | United States | $0.237B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
CVRx (CVRX) | United States | $0.176B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
Inogen (INGN) | United States | $0.172B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.163B | 0.00 |
Accuray (ARAY) | United States | $0.162B | 0.00 |
Anteris Technologies Global (AVR) | Australia | $0.161B | 0.00 |
LENSAR (LNSR) | United States | $0.160B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.110B | 0.00 |
Microbot Medical (MBOT) | United States | $0.099B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
InspireMD (NSPR) | United States | $0.078B | 0.00 |
EDAP TMS S.A (EDAP) | France | $0.067B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
Hyperfine (HYPR) | United States | $0.058B | 0.00 |
Positron (POSC) | United States | $0.054B | 0.00 |
Spectral AI (MDAI) | United States | $0.044B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.043B | 0.00 |
Precision Optics (POCI) | United States | $0.034B | 0.00 |
Envoy Medical (COCH) | United States | $0.033B | 0.00 |
DarioHealth (DRIO) | United States | $0.030B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.017B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
PAVmed (PAVM) | United States | $0.010B | 0.00 |
Tenon Medical (TNON) | United States | $0.008B | 0.00 |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.007B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.001B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.19 |